Pashtoon Kasi/LinkedIn
Jun 3, 2025, 11:42
Pashtoon Kasi Shares Immunotherapy Insights for MSS Colorectal Cancer at ASCO 2025
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, posted on LinkedIn:
“ASCO25 Continuing with the immunotherapy promise for the subset of patients with NO active LIVER METASTASES NLM MSS colorectal cancer, see this.
ADG126 Masked CTLA4 + Pembro
ORR ~ 29% Sustained.
FRUQ + Immunotherapy arm.”
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 20, 2025, 20:20
Jul 20, 2025, 20:10
Jul 20, 2025, 19:54
Jul 20, 2025, 19:20
Jul 20, 2025, 18:59
Jul 20, 2025, 18:27
Jul 20, 2025, 18:12
Jul 20, 2025, 17:37